Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons

Jonathan E. Hood, Jerry W. Jenkins, Dejan Milatovic, Lu Rongzhu, Michael Aschner

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Mefloquine is an effective antimalarial that can cause adverse neurological events including headache, nausea, fatigue, insomnia, anxiety and depression. In this study, we examined the oxidative stress response in primary rat cortical neurons treated with mefloquine by quantifying oxidative stress markers glutathione (GSH) and F2-isoprostanes (F2-isoPs). Furthermore, we examined whether mefloquine induces synaptodendritic degeneration of primary rat cortical neurons. GSH was quantified in cortical neurons after 24-h treatment with mefloquine (0, 1, 5, 10μM) using monochlorobimane. F2-isoPs were quantified in cortical neurons after 24-h treatment with mefloquine (0, 1, 5, 10μM) using a stable isotope dilution method with detection by gas chromatography/mass spectrometry and selective ion monitoring. The concentration dependent decrease in GSH and the concomitant increase of F2-isoPs indicates the presence of oxidative stress in primary rat cortical neurons treated with mefloquine. Following a 24-h treatment with mefloquine, primary rat cortical neurons (0, 5, 10μM) were fixed with 4% paraformaldehyde. Images from eight optical sections covering a distance of 2.88μm on the z-axis were acquired using a confocal laser scanning unit. Traced images were analyzed with NeuroExplorer, a neurophysiological data analysis package. Mefloquine induces a concentration dependent decrease in the number of spines per neuron and the spine density, suggesting that mefloquine induced oxidative stress may be associated with the synaptodendritic degeneration. Together with previous work, there is strong evidence that a relationship exists between calcium homeostasis disruption, ER stress response, the oxidative stress response, and neurodegeneration. Understanding how oxidative stress alters the morphology of cortical neurons treated with mefloquine will provide further insight into the mechanism(s) related to clinically observed adverse neurological events.

Original languageEnglish (US)
Pages (from-to)518-523
Number of pages6
JournalNeuroToxicology
Volume31
Issue number5
DOIs
StatePublished - Sep 2010
Externally publishedYes

Fingerprint

Mefloquine
Oxidative stress
Neurons
Rats
Oxidative Stress
F2-Isoprostanes
Spine
Antimalarials
Sleep Initiation and Maintenance Disorders
Isotopes
Gas chromatography
Gas Chromatography-Mass Spectrometry
Nausea
Dilution
Fatigue
Mass spectrometry
Glutathione
Headache
Lasers
Homeostasis

Keywords

  • Glutathione
  • Isoprostane
  • Mefloquine
  • Neurodegeneration
  • Oxidative stress

ASJC Scopus subject areas

  • Neuroscience(all)
  • Toxicology

Cite this

Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons. / Hood, Jonathan E.; Jenkins, Jerry W.; Milatovic, Dejan; Rongzhu, Lu; Aschner, Michael.

In: NeuroToxicology, Vol. 31, No. 5, 09.2010, p. 518-523.

Research output: Contribution to journalArticle

Hood, Jonathan E. ; Jenkins, Jerry W. ; Milatovic, Dejan ; Rongzhu, Lu ; Aschner, Michael. / Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons. In: NeuroToxicology. 2010 ; Vol. 31, No. 5. pp. 518-523.
@article{fa72e2de95444892a8cf9cec7d25bc28,
title = "Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons",
abstract = "Mefloquine is an effective antimalarial that can cause adverse neurological events including headache, nausea, fatigue, insomnia, anxiety and depression. In this study, we examined the oxidative stress response in primary rat cortical neurons treated with mefloquine by quantifying oxidative stress markers glutathione (GSH) and F2-isoprostanes (F2-isoPs). Furthermore, we examined whether mefloquine induces synaptodendritic degeneration of primary rat cortical neurons. GSH was quantified in cortical neurons after 24-h treatment with mefloquine (0, 1, 5, 10μM) using monochlorobimane. F2-isoPs were quantified in cortical neurons after 24-h treatment with mefloquine (0, 1, 5, 10μM) using a stable isotope dilution method with detection by gas chromatography/mass spectrometry and selective ion monitoring. The concentration dependent decrease in GSH and the concomitant increase of F2-isoPs indicates the presence of oxidative stress in primary rat cortical neurons treated with mefloquine. Following a 24-h treatment with mefloquine, primary rat cortical neurons (0, 5, 10μM) were fixed with 4{\%} paraformaldehyde. Images from eight optical sections covering a distance of 2.88μm on the z-axis were acquired using a confocal laser scanning unit. Traced images were analyzed with NeuroExplorer, a neurophysiological data analysis package. Mefloquine induces a concentration dependent decrease in the number of spines per neuron and the spine density, suggesting that mefloquine induced oxidative stress may be associated with the synaptodendritic degeneration. Together with previous work, there is strong evidence that a relationship exists between calcium homeostasis disruption, ER stress response, the oxidative stress response, and neurodegeneration. Understanding how oxidative stress alters the morphology of cortical neurons treated with mefloquine will provide further insight into the mechanism(s) related to clinically observed adverse neurological events.",
keywords = "Glutathione, Isoprostane, Mefloquine, Neurodegeneration, Oxidative stress",
author = "Hood, {Jonathan E.} and Jenkins, {Jerry W.} and Dejan Milatovic and Lu Rongzhu and Michael Aschner",
year = "2010",
month = "9",
doi = "10.1016/j.neuro.2010.05.005",
language = "English (US)",
volume = "31",
pages = "518--523",
journal = "NeuroToxicology",
issn = "0161-813X",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons

AU - Hood, Jonathan E.

AU - Jenkins, Jerry W.

AU - Milatovic, Dejan

AU - Rongzhu, Lu

AU - Aschner, Michael

PY - 2010/9

Y1 - 2010/9

N2 - Mefloquine is an effective antimalarial that can cause adverse neurological events including headache, nausea, fatigue, insomnia, anxiety and depression. In this study, we examined the oxidative stress response in primary rat cortical neurons treated with mefloquine by quantifying oxidative stress markers glutathione (GSH) and F2-isoprostanes (F2-isoPs). Furthermore, we examined whether mefloquine induces synaptodendritic degeneration of primary rat cortical neurons. GSH was quantified in cortical neurons after 24-h treatment with mefloquine (0, 1, 5, 10μM) using monochlorobimane. F2-isoPs were quantified in cortical neurons after 24-h treatment with mefloquine (0, 1, 5, 10μM) using a stable isotope dilution method with detection by gas chromatography/mass spectrometry and selective ion monitoring. The concentration dependent decrease in GSH and the concomitant increase of F2-isoPs indicates the presence of oxidative stress in primary rat cortical neurons treated with mefloquine. Following a 24-h treatment with mefloquine, primary rat cortical neurons (0, 5, 10μM) were fixed with 4% paraformaldehyde. Images from eight optical sections covering a distance of 2.88μm on the z-axis were acquired using a confocal laser scanning unit. Traced images were analyzed with NeuroExplorer, a neurophysiological data analysis package. Mefloquine induces a concentration dependent decrease in the number of spines per neuron and the spine density, suggesting that mefloquine induced oxidative stress may be associated with the synaptodendritic degeneration. Together with previous work, there is strong evidence that a relationship exists between calcium homeostasis disruption, ER stress response, the oxidative stress response, and neurodegeneration. Understanding how oxidative stress alters the morphology of cortical neurons treated with mefloquine will provide further insight into the mechanism(s) related to clinically observed adverse neurological events.

AB - Mefloquine is an effective antimalarial that can cause adverse neurological events including headache, nausea, fatigue, insomnia, anxiety and depression. In this study, we examined the oxidative stress response in primary rat cortical neurons treated with mefloquine by quantifying oxidative stress markers glutathione (GSH) and F2-isoprostanes (F2-isoPs). Furthermore, we examined whether mefloquine induces synaptodendritic degeneration of primary rat cortical neurons. GSH was quantified in cortical neurons after 24-h treatment with mefloquine (0, 1, 5, 10μM) using monochlorobimane. F2-isoPs were quantified in cortical neurons after 24-h treatment with mefloquine (0, 1, 5, 10μM) using a stable isotope dilution method with detection by gas chromatography/mass spectrometry and selective ion monitoring. The concentration dependent decrease in GSH and the concomitant increase of F2-isoPs indicates the presence of oxidative stress in primary rat cortical neurons treated with mefloquine. Following a 24-h treatment with mefloquine, primary rat cortical neurons (0, 5, 10μM) were fixed with 4% paraformaldehyde. Images from eight optical sections covering a distance of 2.88μm on the z-axis were acquired using a confocal laser scanning unit. Traced images were analyzed with NeuroExplorer, a neurophysiological data analysis package. Mefloquine induces a concentration dependent decrease in the number of spines per neuron and the spine density, suggesting that mefloquine induced oxidative stress may be associated with the synaptodendritic degeneration. Together with previous work, there is strong evidence that a relationship exists between calcium homeostasis disruption, ER stress response, the oxidative stress response, and neurodegeneration. Understanding how oxidative stress alters the morphology of cortical neurons treated with mefloquine will provide further insight into the mechanism(s) related to clinically observed adverse neurological events.

KW - Glutathione

KW - Isoprostane

KW - Mefloquine

KW - Neurodegeneration

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=77956226033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956226033&partnerID=8YFLogxK

U2 - 10.1016/j.neuro.2010.05.005

DO - 10.1016/j.neuro.2010.05.005

M3 - Article

C2 - 20562019

AN - SCOPUS:77956226033

VL - 31

SP - 518

EP - 523

JO - NeuroToxicology

JF - NeuroToxicology

SN - 0161-813X

IS - 5

ER -